IDEXX Laboratories Stock News

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.27 per share a year ago.

Nearly 87 million households -- over two-thirds of the total -- own at least one pet. Spending on pet healthcare could nearly double by 2030 to $112 billion.

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stereotypically, the concept of bidding up publicly traded enterprises based on their environmental, social, and governance scores – the so-called ESG stocks – might seem an extremely risky propos

Animal-loving investors may be interested in exploring opportunities in the pet industry. While there are altruistic reasons for supporting companies that focus on the well-being of our furry friends,

IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts.

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a be

Investors are optimistic about IDEXX's (IDXX) strength in the Companion Animal Group business.

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?

TMO vs. IDXX: Which Stock Is the Better Value Option?

Investors are optimistic about IDEXX's (IDXX) strong global performance.

IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses.

IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians' everyday needs. IDEXX has delivered solid and

The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most.

Here is how Idexx Laboratories (IDXX) and Aeterna Zentaris (AEZS) have performed compared to their sector so far this year.